There is evidence that early treatment of connective tissue in adolescence improves clinical outcomes; thus, recognition of the cutaneous manifestation of CTD is critical. This review summarizes the clinical features that are unique to children and adolescents in cutaneous (CLE) and systemic lupus erythematosus (SLE), juvenile dermatomyositis (JDM), juvenile systemic scleroderma (JSS), juvenile localized scleroderma (JLS), and juvenile inflammatory arthritis (JIA).
|Original language||English (US)|
|Number of pages||19|
|Journal||Adolescent medicine: state of the art reviews|
|State||Published - Apr 1 2011|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health